Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006420
Filing Date
2024-11-12
Accepted
2024-11-12 09:37:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 CORBUS PHARMACEUTICALS HOLDINGS, INC. p24-3024sc13ga.htm SC 13G/A 70521
  Complete submission text file 0000902664-24-006420.txt   72172
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Subject) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88716 | Film No.: 241444282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)